Royal Bank of Canada Lowers Reckitt Benckiser Group (LON:RB) Price Target to GBX 5,300

Reckitt Benckiser Group (LON:RB) had its price target decreased by equities researchers at Royal Bank of Canada from GBX 5,900 ($77.09) to GBX 5,300 ($69.25) in a research note issued on Wednesday, ThisIsMoney.Co.Uk reports. The firm presently has an “underperform” rating on the stock. Royal Bank of Canada’s target price would indicate a potential downside of 8.83% from the stock’s current price.

A number of other research analysts also recently weighed in on RB. HSBC set a GBX 7,700 ($100.61) price objective on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Thursday, October 10th. Berenberg Bank began coverage on shares of Reckitt Benckiser Group in a research report on Wednesday, October 16th. They issued a “buy” rating and a GBX 7,420 ($96.96) price objective for the company. UBS Group set a GBX 6,500 ($84.93) price objective on shares of Reckitt Benckiser Group and gave the stock a “neutral” rating in a research report on Tuesday. Jefferies Financial Group set a GBX 5,550 ($72.52) price objective on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Tuesday. Finally, Sanford C. Bernstein set a GBX 7,600 ($99.31) price objective on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Friday, October 18th. Four equities research analysts have rated the stock with a sell rating, three have given a hold rating and ten have issued a buy rating to the stock. Reckitt Benckiser Group currently has an average rating of “Hold” and an average price target of GBX 6,977.65 ($91.18).

Shares of Reckitt Benckiser Group stock opened at GBX 5,813 ($75.96) on Wednesday. The firm has a 50-day simple moving average of GBX 6,251.10 and a two-hundred day simple moving average of GBX 6,264.74. The company has a market cap of $41.08 billion and a P/E ratio of 29.18. Reckitt Benckiser Group has a fifty-two week low of GBX 5,559 ($72.64) and a fifty-two week high of GBX 6,862 ($89.66). The company has a debt-to-equity ratio of 85.08, a quick ratio of 0.43 and a current ratio of 0.59.

In related news, insider Adrian Nevil Hennah sold 81,063 shares of the company’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of GBX 6,399 ($83.61), for a total transaction of £5,187,221.37 ($6,778,023.48).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: How Do You Calculate Return on Investment (ROI)?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.